Search

everythinglearnresearchcommunity

for

Search:↓

Linoleic acid and magnesium are key in alopecia areata progression, and tofacitinib can help by affecting their pathway.

Rapamycin and anti-EGFR antibody reduce LAM/TSC cell migration and blood vessel growth in the uterus.

New oral treatments for adult hair loss show promise, especially JAK inhibitors, with mild side effects.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

JAK inhibitors effectively and safely treat alopecia areata with few serious side effects.

The new compound was more effective than finasteride in reducing markers of hair loss and prostate issues in cell tests.

Deucravacitinib did not significantly improve hair regrowth in alopecia areata patients.

A small group of slow-growing cells causes basal cell carcinoma to return after treatment.

ADCs can effectively treat breast cancer but may cause side effects like nausea and hair loss.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

Talquetamab may cause hair loss and skin issues.

The combination of encorafenib and binimetinib caused few skin issues.

Tofacitinib treatment for hair loss may worsen acne.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

No effective treatment exists to stimulate hair growth in atrichia with papular lesions.

Sonidegib often causes hair loss, and LC-OCT helps identify early signs.

Tofacitinib works well for treating alopecia areata, especially when combined with corticosteroids, but is less effective if the disease has lasted over 2 years.

Researchers found three different ways drugs work to treat hair loss from alopecia areata and identified key factors for personalized treatment.

Oral ritlecitinib and baricitinib are promising treatments for severe alopecia areata due to their balance of effectiveness and safety.

Sorafenib often causes mucositis, hand-foot syndrome, rash, alopecia, diarrhea, and fatigue.

ZD1839, a cancer drug, can cause mild skin rashes that are treatable without stopping the medication.

Erlotinib can cause scalp pustules and hair loss, needing early treatment with antibiotics and steroids.

Platycladus orientalis leaf extract helps hair grow by activating certain proteins.

ATR04-484 ointment shows promise for treating skin issues from cancer therapies.

Topical JAK inhibitors may help children with alopecia areata regrow hair.

EGFR-targeting cancer drugs can cause skin rashes and other side effects.

Nivolumab can cause hair loss as a rare side effect.

Three compounds from Dadap leaves may help treat hair loss.

Sorafenib after liver surgery may increase survival for some liver cancer patients.